Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery

Advanced Drug Delivery Reviews

Volumn 65, Issue 5, 2013, Pages 677-688

  Montenegro, Jose Maria ^a   Grazu, Valeria ^b   Sukhanova, Alyona ^c,d   Agarwal, Seema ^e   de la Fuente, Jesus M ^b   Nabiev, Igor ^c,d   Greiner, Andreas ^e   Parak, Wolfgang J ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^d NATIONAL RESEARCH NUCLEAR UNIVERSITY MEPHI   (Russian Federation)

^e UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Antibodies; Bioconjugation; Colloidal nanoparticles; Controlled targeting; Drug delivery; Gold nanoparticles; Magnetic nanoparticles; Molecular recognition; Quantum dots

Indexed keywords

BIO-CONJUGATION; COLLOIDAL NANOPARTICLES; CONTROLLED TARGETING; GOLD NANOPARTICLES; MAGNETIC NANO-PARTICLES;

ANTIBODIES; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; DRUG INTERACTIONS; FREE RADICALS; MOLECULAR RECOGNITION; MOLECULES; SEMICONDUCTOR QUANTUM DOTS; TISSUE;

NANOPARTICLES;

ANTIBODY CONJUGATE; CARCINOEMBRYONIC ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; INORGANIC NANOPARTICLE; LIGAND; MACROGOL; MAGNETIC NANOPARTICLE; METAL NANOPARTICLE; MONOCLONAL ANTIBODY; NANOPARTICLE; POLYCLONAL ANTIBODY; POLYFUNCTIONAL GROUP; POLYMER; QUANTUM DOT; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN ANTIBODY REACTION; BINDING SITE; CHEMICAL INTERACTION; CHEMICAL MODIFICATION; COLLOID; CONTROLLED DRUG DELIVERY; DRUG DELIVERY SYSTEM; GENE TARGETING; IMMUNE RESPONSE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; SYNTHESIS;

ANIMALS; ANTIBODIES; DRUG DELIVERY SYSTEMS; HUMANS; INORGANIC CHEMICALS; NANOPARTICLES;

EID: 84878408367     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.12.003     Document Type: Review

References (154)

1. Holmquist L., Vesterberg O. Direct on air sampling filter quantification of cat allergen. J. Biochem. Biophys. Methods 2002, 51:17-25.
2. Wels W., Biburger M., Muller T., Dalken B., Giesubel U., Tonn T., Uherek C. Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors. Cancer Immunol. Immunother. 2004, 53:217-226.
3. Garber E., Venkateswaran K., O'Brien T. Simultaneous multiplex detection and confirmation of the proteinaceous toxins abrin, ricin, botulinum toxins, and Staphylococcus enterotoxins A, B, and C in food. J. Agric. Food Chem. 2010, 58:6600-6607.
4. Williams A., Galfre G., Milstein C. Analysis of cell-surfaces by xenogeneic myeloma-hybrid antibodies - Differentiation antigens of rat lymphocytes. Cell 1977, 12:663-673.
5. DeLisa M., Zhang Z., Shiloach M., Pilevar S., Davis C., Sirkis J., Bentley W. Evanescent wave long period fiber Bragg grating as an immobilized antibody biosensor. Anal. Chem. 2000, 72:2895-2900.
6. Popii V., Baumann G. Laboratory measurement of growth hormone. Clin. Chim. Acta 2004, 350:1-16.
7. Yin W., Liu J., Zhang T., Li W., Liu W., Meng M., He F., Wan Y., Feng C., Wang S., Lu X., Xi R. Preparation of monoclonal antibody for melamine and development of an indirect competitive ELISA for melamine detection in raw milk, milk powder, and animal feeds. J. Agric. Food Chem. 2010, 58:8152-8157.
8. Ai X., Butts B., Vora K., Li W., Tache-Talmadge C., Fridman A., Mehmet H. Generation and characterization of antibodies specific for caspase-cleaved neo-epitopes: a novel approach. Cell Death Dis. 2011, 2.
9. Singh A., Senapati D., Wang S., Griffin J., Neely A., Candice P., Naylor K., Varisli B., Kalluri J., Ray P. Gold nanorod based selective identification of Escherichia coli bacteria using two-photon Rayleigh scattering spectroscopy. ACS Nano 2009, 3:1906-1912.
10. Pavao M., Traish A. Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor alpha and beta. Steroids 2001, 66:1-16.
11. Wang S., Mamedova N., Kotov N.A., Chen W., Studer J. Antigen/antibody immunocomplex from CdTe nanoparticle bioconjugates. Nano Lett. 2002, 2:817-822.
12. Perez J., Vargis E., Russ P., Haselton F., Wright D. Detection of respiratory syncytial virus using nanoparticle amplified immuno-polymerase chain reaction. Anal. Biochem. 2011, 410:141-148.
13. Yang H., Qu L., Wimbrow A., Jiang X., Sun Y. Rapid detection of Listeria monocytogenes by nanoparticle-based immunomagnetic separation and real-time PCR. Int. J. Food Microbiol. 2007, 118:132-138.
14. Wacker R., Ceyhan B., Alhorn P., Schueler D., Lang C., Niemeyer C.M. Magneto Immuno-MR: a novel immunoassay based on biogenic magnetosome nanoparticles. Biochem. Biophys. Res. Commun. 2007, 357:391-396.
15. Shi D. Integrated multifunctional nanosystems for medical diagnosis and treatment. Adv. Funct. Mater. 2009, 19:3356-3373.
16. 4 composite nanospheres for in vivo imaging and hyperthermia. Adv. Mater. 2009, 21:2170-2173.
17. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
18. Pankhurst Q.A., Connolly J., Jones S.K., Dobson J. Applications of magnetic nanoparticles in biomedicine. J. Phys. D Appl. Phys. 2003, 36:R167-R181.
19. El-Sayed I.H., Huang X., El-Sayed M.A. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 2005, 5:829-834.
20. Byrappa K., Ohara S., Adschiri T. Nanoparticles synthesis using supercritical fluid technology - towards biomedical applications. Adv. Drug Deliv. Rev. 2008, 60:299-327.
21. Eastoe J., Hollamby M., Hudson L. Recent advances in nanoparticle synthesis with reversed micelles. Adv. Colloid Interface Sci. 2006, 128:5-15.
22. Dahl J., Maddux B., Hutchison J. Toward greener nanosynthesis. Chem. Rev. 2007, 107:2228-2269.
23. Cushing B., Kolesnichenko V., O'Connor C. Recent advances in the liquid-phase syntheses of inorganic nanoparticles. Chem. Rev. 2004, 104:3893-3946.
24. Sperling R.A., Parak W.J. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Phil. Trans. R. Soc. A 2010, 368:1333-1383.
25. Lu A.H., Salabas E.L., Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. 2007, 46:1222-1244.
26. Hyeon T. Chemical synthesis of magnetic nanoparticles. Chem. Commun. 2003, 8:927-934.
27. P. Rivera Gil, D. Jimenez de Aberasturi, V. Wulf, B. Pelaz, P. del Pino, Y. Zhao, J. de la Fuente, I. Ruiz de Larramendi, T. Rojo, X.-J. Liang, W.J. Parak, The Challenge To Relate the Physicochemical Properties of Colloidal Nanoparticles to Their Cytotoxicity, Acc. Chem. Res. (Article ASAP) . doi:10.1021/ar300039j.
28. Hermanson G.T. Bioconjugate Techniques 2008, Academic Press, San Diego. 2nd ed.
29. Bartczak D., Kanaras A. Preparation of peptide-functionalized gold nanoparticles using one pot EDC/Sulfo-NHS coupling. Langmuir 2011, 27:10119-10123.
30. Sukhanova A., Even-Desrumeaux K., Kisserli A., Tabary T., Reveil B., Millot J.M., Chames P., Baty D., Artemyev M., Oleinikov V., Pluot M., Cohen J.H.M., Nabiev I. Oriented conjugates of single-domain antibodies and quantum dots: toward new generation of ultra-small diagnostic nanoprobes. Nanomedicine: NBM 2011, 10.1016/j.nano.2011.07.007.
31. Wilson R., Chen Y., Aveyard J. One molecule per particle method for functionalising nanoparticles. Chem. Commun. (Camb.) 2004, 1156-1157.
32. Levy R., Wang Z.X., Duchesne L., Doty R.C., Cooper A.I., Brust M., Fernig D.G. A generic approach to monofunctionalized protein-like gold nanoparticles based on immobilized metal ion affinity chromatography. ChemBioChem 2006, 7:592-594.
33. Howarth M., Liu W.H., Puthenveetil S., Zheng Y., Marshall L.F., Schmidt M.M., Wittrup K.D., Bawendi M.G., Ting A.Y. Monovalent, reduced-size quantum dots for imaging receptors on living cells. Nat. Methods 2008, 5:397-399.
34. Hostetler M.J., Green S.J., Stokes J.J., Murray R.W. Monolayers in three dimensions: synthesis and electrochemistry of -functionalized alkanethiolate-stabilized gold cluster compounds. J. Am. Chem. Soc. 1996, 118:4212-4213.
35. Dai Q., Worden J.G., Trullinger J., Huo Q. A "nanonecklace" synthesized from monofunctionalized gold nanoparticles. J. Am. Chem. Soc. 2005, 127:8008-8009.
36. Abed O., Vaskevich A., Arad-Yellin R., Shanzer A., Rubinstein I. Preparative manipulation of gold nanoparticles by reversible binding to a polymeric solid support. Chem. Eur. J. 2005, 11:2836-2841.
37. Worden J.G., Dai Q., Shaffer A.W., Huo Q. Monofunctional group-modified gold nanoparticles from solid phase synthesis approach: solid support and experimental condition effect. Chem. Matter. 2004, 16:3746-3755.
38. Liu X., Worden J.G., Dai Q., Zou J., Wang J., Huo Q. Monofunctional gold nanoparticles prepared via a noncovalent-interaction-based solid-phase modification approach. Small 2006, 2:1126-1129.
39. Worden J.G., Shaffer A.W., Huo Q. Controlled functionalization of gold nanoparticles through a solid phase synthesis approach. Chem. Commun. 2004, 2004:518-519.
40. Shaffer A.W., Worden J.G., Huo G. Comparison study of the solution phase versus solid phase place exchange reactions in the controlled functionalization of gold nanoparticles. Langmuir 2004, 20:8343-8351.
41. Sung K.M., Mosley D.W., Peelle B.R., Zhang S.G., Jacobson J.M. Synthesis of monofunctionalized gold nanoparticles by Fmoc solid-phase reactions. J. Am. Chem. Soc. 2004, 126:5064-5065.
42. DeVries G.A., Brunnbauer M., Hu Y., Jackson A.M., Long B., Neltner B.T., Uzun O., Wunsch B.H., Stellacci F. Divalent metal nanoparticles. Science 2007, 315:358-361.
43. Krüger C., Agarwal S., Greiner A. Stoichiometric functionalization of gold nanoparticles in solution through a free radical polymerization approach. J. Am. Chem. Soc. 2008, 130:2710-2711.
44. Zanchet D., Micheel C.M., Parak W.J., Gerion D., Alivisatos A.P. Electrophoretic isolation of discrete Au nanocrystal/DNA conjugates. Nano Lett. 2001, 1:32-35.
45. Claridge S.A., Liang H.W., Basu S.R., Frechet J.M.J., Alivisatos A.P. Isolation of discrete nanoparticle-DNA conjugates for plasmonic applications. Nano Lett. 2008, 8:1202-1206.
46. Sperling R.A., Pellegrino T., Li J.K., Chang W.H., Parak W.J. Electrophoretic separation of nanoparticles with a discrete number of functional groups. Adv. Funct. Mater. 2006, 16:943-948.
47. Lin C.-A.J., Sperling R.A., Li J.K., Yang T.-Y., Li P.-Y., Zanella M., Chang W.H., Parak W.J. Design of an amphiphilic polymer for nanoparticle coating and functionalization. Small 2008, 4:334-341.
48. Loweth C.J., Caldwell W.B., Peng X.G., Alivisatos A.P., Schultz P.G. DNA-based assembly of gold nanocrystals. Angew. Chem. Int. Ed. 1999, 38:1808-1812.
49. Zanchet D., Micheel C.M., Parak W.J., Gerion D., Williams S.C., Alivisatos A.P. Electrophoretic and structural studies of DNA-directed Au nanoparticle groupings. J. Phys. Chem. B 2002, 106:11758-11763.
50. Parak W.J., Pellegrino T., Micheel C.M., Gerion D., Williams S.C., Alivisatos A.P. Conformation of oligonucleotides attached to gold nanocrystals probed by gel electrophoresis. Nano Lett. 2003, 3:33-36.
51. Pellegrino T., Sperling R.A., Alivisatos A.P., Parak W.J. Gelelectrophoresis of Gold-DNA Nanoconjugates. J. Biomed. Biotechnol. 2007, 2007. (article ID 26796).
52. Sperling R.A., Liedl T., Duhr S., Kudera S., Zanella M., Lin C.-A.J., Chang W.H., Braun D., Parak W.J. Size determination of (bio-) conjugated water-soluble colloidal nanoparticles - a comparison of different techniques. J. Phys. Chem. C 2007, 111:11552-11559.
53. Itano M.S., Neumann A.K., Liu P., Zhang F., Gratton E., Parak W.J., Thompson N.L., Jacobson K. DC-SIGN and influenza hemagglutinin dynamics in plasma membrane microdomains are markedly different. Biophys. J. 2011, 100:2662-2670.
54. Mullen D.G., Fang M., Desai A., Baker J.R., Orr B.G., Banaszak Holl M.M. A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates. ACS Nano 2010, 4:657-670.
55. Liao J., Zhang Y., Yu W., Xu L., Ge C., Liu J., Gua N. Linear aggregation of gold nanoparticles in ethanol. Colloids Surf., A Physicochem. Eng. Asp. 2003, 223:177-183.
56. Claridge S.A., Goh S.L., Fréchet J.M.J., Williams S.C., Micheel C.M., Alivisatos A.P. Directed assembly of discrete gold nanoparticle groupings using branched DNA scaffolds. Chem. Mater. 2005, 17:1628-1635.
57. Bokern S., Gries K., Agarwal S., Görtz H.-H., Warzelhan V., Greiner A. Precisely designed gold nanoparticles by surface polymerization - artificial molecules as building blocks for novel materials. Adv. Funct. Mater. 2011, 21:3753-3759.
58. Carstairs H., Lymperopoulos K., Kapanidis A., Bath J., Turberfield A. DNA monofunctionalization of quantum dots. ChemBioChem 2009, 10:1781-1783.
59. Weiss S. Fluorescence spectroscopy of single biomolecules. Science 1999, 283:1676-1683.
60. Bumb A., Sarkar S.K., Wu X.S., Brechbiel M.W., Neuman K.C. Quantitative characterization of fluorophores in multi-component nanoprobes by single-molecule fluorescence. Biomed. Opt. Express 2011, 2:2761-2769.
61. Lei J., Ju H. Signal amplification using functional nanomaterials for biosensing. Chem. Soc. Rev. 2012, 41:2122-2134.
62. Pérez-López B., Merkoçi A. Nanoparticles for the development of improved (bio)sensing systems. Anal. Bioanal. Chem. 2011, 399:1577-1590.
63. Keppler A., Kindermann M., Gendreizig S., Pick H., Vogel H., Johnsson K. Labeling of fusion proteins of O-6-alkylguanine-DNA alkyltransferase with small molecules in vivo and in vitro. Methods 2004, 32:437-444.
64. Colombo M., Mazzucchelli S., Montenegro J.M., Galbiati E., Corsi F., Parak W.J., Prosperi D. Protein oriented ligation on nanoparticles exploiting O6-Alkylguanine-DNA Transferase (SNAP) genetically encoded fusion. Small 2012, 8:1492-1497.
65. Amit A., Mariuzza R., Phillips S., Poljak R. 3-Dimensional structure of an antigen-antibody complex at 2.8-A resolution. Science 1986, 233:747-753.
66. Nechansky A., Robertson M., Albrecht B., Apgar J., Kricek F. Inhibition of antigen-induced mediator release from IgE-sensitized cells by a monoclonal anti-Fc epsilon RI alpha-chain receptor antibody: implications for the involvement of the membrane-proximal alpha-chain region in Fc epsilon RI-mediated cell activation. J. Immunol. 2001, 166:5979-5990.
67. Liu M., Pan J., Ji H., Zhao B., Zhang S. Vitellogenin mediates phagocytosis through interaction with FcgammaR. Mol. Immunol. 2011, 49:211-218.
68. Semple J., Aslam R., Kim M., Speck E., Freedman J. Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets. Blood 2007, 109:4803-4805.
69. Wellington M., Bliss J., Haidaris C. Enhanced phagocytosis of Candida species mediated by opsonization with a recombinant human antibody single-chain variable fragment. Infect. Immun. 2003, 71:7228-7231.
70. Jia L., Xu Y., Zhang C., Wang Y., Chong H., Qiu S., Wang L., Zhong Y., Liu W., Sun Y., Qiao F., Tomlinson S., Song H., Zhou Y., He Y. A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement. Virol. J. 2010, 7.
71. Lin P., Wright J. Surfactant protein A binds to IgG and enhances phagocytosis of IgG-opsonized erythrocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L1199-L1206.
72. Padlan E.A. Anatomy of the antibody molecule. Mol. Immunol. 1994, 31:169-217.
73. Pathak S., Davidson M.C., Silva G.A. Characterization of the functional binding properties of antibody conjugated quantum dots. Nano Lett. 2007, 7:1839-1845.
74. Attarwala H. Role of antibodies in cancer targeting. J. Nat. Sci. Biol. Med. 2010, 1:53-56.
75. Holliger P., Hudson P. Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 2005, 23:1126-1136.
76. Bio-Rad Protein Assay, in, Bio-Rad.
77. Sukhanova A., Even-Desrumeaux K., Chames P., Baty D., Artemyev M., Oleinikov V., Nabiev I. Engineering of ultra-small diagnostic nanoprobes through oriented conjugation of single-domain antibodies and quantum dots. Nat. Protoc. Exch. 2012, 10.1038/protex.2012.042.
78. Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin. Cancer Biol. 1999, 9:67-81.
79. Jain R.K. Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 1987, 6:559-593.
80. Zhao X., Pan F., Lu J. Interfacial assembly of proteins and peptides: recent examples studied by neutron reflection. J. R. Soc. Interface 2009, 6:S659-S670.
81. Zhao X., Pan F., Cowsill B., Lu J. Interfacial immobilization of monoclonal antibody and detection of human prostate-specific antigen. Langmuir 2011, 27:7654-7662.
82. Puertas S., Moros M., Fernandez-Pacheco R., Ibarra M.R., Grazu V., de la Fuente J.M. Designing novel nano-immunoassays: antibody orientation versus sensitivity. J. Phys. D: Appl. Phys. 2010, 43:474012.
83. Wang J., Cao Y., Xu Y., Li G. Colorimetric multiplexed immunoassay for sequential detection of tumor markers. Biosens. Bioelectron. 2009, 25:532-536.
84. Lin P.-C., Chen S.-H., Wang K.-Y., Chen M.-L., Adak A.K., Hwu J.-R.R., Chen Y.-J., Lin C.-C. Fabrication of Oriented Antibody-Conjugated Magnetic Nanoprobes and Their Immunoaffinity Application. Anal. Chem. 2009, 81:8774-8782.
85. Koh I., Hong R., Weissleder R., Josephson L. Nanoparticle-target interactions parallel antibody-protein interactions. Anal. Chem. 2009, 81:3618-3622.
86. Kaittanis C., Santra S., Perez J.M. Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media. J. Am. Chem. Soc. 2009, 131:12780-12791.
87. Granade T.C., Workman S., Wells S.K., Holder A.N., Owen S.M., Pau C.-P. Rapid detection and differentiation of antibodies to HIV-1 and HIV-2 using multivalent antigens and magnetic immunochromatography testing. Clin. Vaccine Immunol. 2010, 17:1034-1039.
88. Gaster R.S., Hall D.A., Nielsen C.H., Osterfeld S.J., Yu H., Mach K.E., Wilson R.J., Murmann B., Liao J.C., Gambhir S.S., Wang S.X. Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat. Med. 2009, 15:1327-1332.
89. Baio G., Fabbi M., Salvi S., de Totero D., Truini M., Ferrini S., Neumaier C.E. Two-step in vivo tumor targeting by biotin-conjugated antibodies and superparamagnetic nanoparticles assessed by magnetic resonance imaging at 1.5 T. Mol. Imaging Biol. 2010, 12:305-315.
90. Aurich K., Glöckl G., Romanus E., Weber P., Nagel S., Weitschies W. Magneto-optical relaxation measurements for the characterization of biomolecular interactions. J. Phys. Condens. Matter 2006, 18:S2847-S2863.
91. Jung Y., Lee J., Jung H., Chung B. Self-directed and self-oriented immobilization of antibody by protein G-DNA conjugate. Anal. Biochem. 2007, 79:6534-6541.
92. Kumar S., Aaron J., Sokolov K. Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat. Protoc. 2008, 3:314-320.
93. Jung Y., Jeong J., Chung B. Recent advances in immobilization methods of antibodies on solid supports. Analyst 2008, 133:697-701.
94. Pavlickova P., Schneider E., Hug H. Advances in recombinant antibody microarrays. Clin. Chim. Acta 2004, 343:17-35.
95. Torcello-Gomez A., Santander-Ortega M., Peula-Garcia J., Maldonado-Valderrama J., Galvez-Ruiz M., Ortega-Vinuesa J., Martin-Rodriguez A. Adsorption of antibody onto Pluronic F68-covered nanoparticles: link with surface properties. Soft Matter 2011, 7:8450-8461.
96. Rayavarapu R.G., Petersen W., Ungureanu C., Post J.N., van Leeuwen T.G., Manohar S. Synthesis and bioconjugation of gold nanoparticles as potential molecular probes for light-based imaging techniques. Int. J. Biomed. Imaging 2007, 2007:29817.
97. Goldman E.R., Mattoussi H., Anderson G.P., Medintz I.L., Mauro J.M. Fluoroimmunoassays using antibody-conjugated quantum dots. Methods Mol. Biol. 2005, 303:19-34.
98. Wang X.-Y., Ma Q., Li Y.-B., Li B., Su X.-G., Jin Q.-H. Studies on fluorescence resonance energy transfer between dyes and water-soluble quantum dots. Luminescence 2005, 20:251-255.
99. van der Voort D., Pelsers M., Korf J., Hermens W., Glatz J. A continuous displacement immunoassay for human heart-type fatty acid-binding protein in plasma. J. Immunol. Methods 2004, 295:1-8.
100. Wu P., He X., Wang K., Tan W., Ma D., Yang W., He C. Imaging breast cancer cells and tissues using peptide-labeled fluorescent silica nanoparticles. J. Nanosci. Nanotechnol. 2008, 8:2483-2487.
101. Puertas S., Batalla P., Moros M., Polo E., del Pino P., Guisan J.M., Grazu V., de la Fuente J.M. Taking advantage of unspecific interactions to produce highly active magnetic nanoparticle-antibody conjugates. ACS Nano 2011, 5:4521-4528.
102. Jana N.R., Ying J.Y. Synthesis of functionalized Au nanoparticles for protein detection. Adv. Mater. 2008, 20:430-434.
103. Barat B., Sirk S., McCabe K., Li J., Lepin E., Remenyi R., Koh A., Olafsen T., Gambhir S., Weiss S., Wu A. Cys-diabody quantum dot conjugates (ImmunoQdots) for cancer marker detection. Bioconjug. Chem. 2009, 20:1474-1481.
104. Kong X., Qiao F., Qi H., Li F. One-step preparation of antibody and oligonucleotide dual-labeled gold nanoparticle bio-probes and their properties. Biotechnol. Lett. 2008, 30:2071-2077.
105. Kim E., Stanton J., Vega R., Kunstman K., Mirkin C., Wolinsky S. A real-time PCR-based method for determining the surface coverage of thiol-capped oligonucleotides bound onto gold nanoparticles. Nucleic Acids Res. 2006, 34.
106. Ho J., Hsu W., Liao W., Chiu J., Chen M., Chang H., Li C. Ultrasensitive electrochemical detection of biotin using electrically addressable site-oriented antibody immobilization approach via aminophenyl boronic acid. Biosens. Bioelectron. 2010, 26:1021-1027.
107. Mahmoud W., Rousserie G., Reveil B., Tabary T., Millot J., Artemyev M., Oleinikov V., Cohen J., Nabiev I., Sukhanova A. Advanced procedures for labeling of antibodies with quantum dots. Anal. Biochem. 2011, 416:180-185.
108. Brody T. Multistep denaturation and hierarchy of disulfide bond cleavage of a monoclonal antibody. Anal. Biochem. 1997, 247:247-256.
109. Yamaoka K., Ingendoh A., Tsubuki S., Nagai Y., Sanai Y. Structural and functional characterization of a novel tumor-derived rat galectin-1 having transforming growth factor (TGF) activity: the relationship between intramolecular disulfide bridges and TGF activity. J. Biochem. 1996, 119:878-886.
110. Torrance L., Ziegler A., Pittman H., Paterson M., Toth R., Eggleston I. Oriented immobilisation of engineered single-chain antibodies to develop biosensors for virus detection. J. Virol. Methods 2006, 134:164-170.
111. Bourg M.-C., Badia A., Lennox R.B. Gold-sulfur bonding in 2D and 3D self-assembled monolayers: XPS characterization. J. Phys. Chem. B 2000, 104:6562-6567.
112. Bain C.D., Whitesides G.M. Molecular-level control over surface order in self-assembled monolayer films of thiols on gold. Science 1988, 240:62-63.
113. Tour J.M., Jones L., Pearson D.L., Lamba J.J.S., Burgin T.P., Whitesides G.M., Allara D.L., Parikh A.N., Atre S.V. Self-assembled monolayers and multilayers of conjugated thiols, alpha, omega-dithiols, and thioacetyl-containing adsorbates - Understanding attachments between potential molecular wires and gold surfaces. J. Am. Chem. Soc. 1995, 117:9529-9534.
114. Bain C.D., Troughton E.B., Tao Y.-T., Evall J., Whitesides G.M., Nuzzo R.G. Formation of monolayer films by the spontaneous assembly of organic thiols from solution onto gold. J. Am. Chem. Soc. 1989, 111:321-335.
115. Yoshimoto K., Nishio M., Sugasawa H., Nagasaki Y. Direct observation of adsorption-induced inactivation of antibody fragments surrounded by mixed-PEG layer on a gold surface. J. Am. Chem. Soc. 2010, 132:7982-7989.
116. Yoon T.-J., Yu K.N., Kim E., Kim J.S., Kim B.G., Yun S.-H., Sohn B.-H., Cho M.-H., Lee J.-K., Park S.B. Specific targeting, cell sorting, and bioimaging with smart magnetic silica core-shell nanomaterials. Small 2006, 2:209-215.
117. van der Vlies A.J., O'Neil C.P., Hasegawa U., Hammond N., Hubbell J.A. Synthesis of pyridyl disulfide-functionalized nanoparticles for conjugating thiol-containing small molecules, peptides, and proteins. Bioconjug. Chem. 2010, 21:653-662.
118. Araki K., Mizuguchi E., Tanaka H., Takuji O. Preparation of very reactive thiol-protected gold nanoparticles: revisiting the Brust-Schiffrin method. J. Nanosci. Nanotechnol. 2006, 6:708-712.
119. Zhang J., Fu Y., Li G., Zhao R., Lakowicz J. Direct observation of chemokine receptors 5 on T-lymphocyte cell surfaces using fluorescent metal nanoprobes 2: approximation of CCR5 populations. Biochem. Biophys. Res. Commun. 2011, 407:63-67.
120. Stuchinskaya T., Moreno M., Cook M., Edwards D., Russell D. Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates. Photochem. Photobiol. Sci. 2011, 10:822-831.
121. Kim H., Park J., Cho I., Kim S., Paek S., Lee H. Selective immobilization of proteins on gold dot arrays and characterization using chemical force microscopy. J. Colloid Interface Sci. 2009, 334:161-166.
122. Haun J., Pepper L., Boder E., Hammer D. Using engineered single-chain antibodies to correlate molecular binding properties and nanoparticle adhesion dynamics. Langmuir 2011, 27:13701-13712.
123. Das J., Aziz M., Yang H. A nanocatalyst-based assay for proteins: DNA-free ultrasensitive electrochemical detection using catalytic reduction of p-nitrophenol by gold-nanoparticle labels. J. Am. Chem. Soc. 2006, 128:16022-16023.
124. Dinauer N., Balthasar S., Weber C., Kreuter J., Langer K., von Briesen H. Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes. Biomaterials 2005, 26:5898-5906.
125. Reznik G., Vajda S., Smith C., Cantor C., Sano T. Streptavidins with intersubunit crosslinks have enhanced stability. Nat. Biotechnol. 1996, 14:1007-1011.
126. Gonzalez M., Bagatolli L.A., Echabe I., Arrondo J.L., Argarana C.E., Cantor C.R., Fidelio G.D. Interaction of biotin with streptavidin. Thermostability and conformational changes upon binding. J. Biol. Chem. 1997, 272:11288-11294.
127. Gonzalez M., Argarana C., Fidelio G. Extremely high thermal stability of streptavidin and avidin upon biotin binding. Biomol. Eng. 1999, 16:67-72.
128. Schiestel T., Brunner H., Tovar G.E.M. Controlled surface functionalization of silica nanospheres by covalent conjugation reactions and preparation of high density streptavidin nanoparticles. J. Nanosci. Nanotechnol. 2004, 4:504-511.
129. Li S., Liu H., He N. Covalent binding of streptavidin on gold magnetic nanoparticles for bead array fabrication. J. Nanosci. Nanotechnol. 2010, 10:4875-4882.
130. Lim K., Huang H., Pralle A., Park S. Engineered streptavidin monomer and dimer with improved stability and function. Biochemistry 2011, 50:8682-8691.
131. Park J., Cho I., Moon D., Paek S., Lee T. ToF-SIMS and PCA of surface-immobilized antibodies with different orientations. Surf. Interface Anal. 2011, 43:285-289.
132. Cho I., Paek E., Lee H., Kang J., Kim T., Paek S. Site-directed biotinylation of antibodies for controlled immobilization of solid surfaces. Anal. Biochem. 2007, 365:14-23.
133. Lee J., Park H., Jung Y., Kim J., Jung S., Chung B. Direct immobilization of protein G variants with various numbers of cysteine residues on a gold surface. Anal. Chem. 2007, 79:2680-2687.
134. Patrie S., Mrksich M. Self-assembled monolayers for MALDI-TOF mass spectrometry for immunoassays of human protein antigens. Anal. Chem. 2007, 79:5878-5887.
135. Fowler J., Stuart M., Wong D. Self-assembled layer of thiolated Protein G as an immunosensor scaffold. Anal. Chem. 2007, 79:350-354.
136. Gao D., McBean N., Schultz J., Yan Y., Mulchandani A., Chen W. Fabrication of antibody arrays using thermally responsive elastin fusion proteins. J. Am. Chem. Soc. 2006, 128:676-677.
137. Protein A/G Recombinant PROSPEC.
138. Protein A/G Biovision, in.
139. Pierce Recombinant Protein A/G and Conjugates, in.
140. Lee J.H., Choi H.K., Lee S.Y., Lim M.-W., Chang J.H. Enhancing immunoassay detection of antigens with multimeric protein Gs. Biosens. Bioelectron. 2011, 28:146-151.
141. Iijima M., Kadoya H., Hatahira S., Hiramatsu S., Jung G., Martin A., Quinn J., Jung J., Jeong S.-Y., Choi E.K., Arakawa T., Hinako F., Kusunoki M., Yoshimoto N., Niimi T., Tanizawa K., Kuroda S. Nanocapsules incorporating IgG Fc-binding domain derived from Staphylococcus aureus Protein A for displaying IgGs on immunosensor chips. Biomaterials 2011, 32:1455-1464.
142. Hazarika P., Ceyhan B., Niemeyer C.M. Sensitive detection of proteins using difunctional DNA-gold nanoparticles. Small 2005, 1:844-848.
143. Niemeyer C.M., Ceyhan B. DNA-directed functionalization of colloidal gold with proteins. Angew. Chem. Int. Ed. 2001, 40:3685-3688.
144. Saerens D., Huang L., Bonroy K., Muyldermans S. Antibody fragments as probe in biosensor development. Sensors 2008, 8:4669-4686.
145. Hernandez K., Fernandez-Lafuente R. Control of protein immobilization: coupling immobilization and site-directed mutagenesis to improve biocatalyst or biosensor performance. Enzyme Microb. Technol. 2011, 48:107-122.
146. Mateo C., Grazu V., Palomo J.M., Lopez-Gallego F., Fernandez-Lafuente R., Guisan J.M. Immobilization of enzymes on heterofunctional epoxy supports. Nat. Protoc. 2007, 2:1022-1033.
147. Batalla P., Fuentes M., Mateo C., Grazu V., Fernandez-Lafuente R., Guisan J.M. Covalent immobilization of antibodies on finally inert support surfaces through their surface regions having the highest densities in carboxyl groups. Biomacromolecules 2008, 9:2230-2236.
148. Nareoja T., Maattanen A., Peltonen J., Hanninen P., Harma H. Impact of surface defects and denaturation of capture surface proteins on nonspecific binding in immunoassays using antibody-coated polystyrene nanoparticle labels. J. Immunol. Methods 2009, 347:24-30.
149. Grazu V., Moros N., Espinel C. Nanocarriers as Nanomedicines: Design Concepts and Recent Advances in Nanobiotechnology 2012, Elsevier, London. J.M. de la Fuente, V. Grazu (Eds.).
150. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Bombelli F.B., Dawson K.A. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133:2525-2534.
151. Rivera Gil P., Parak W.J. Composite nanoparticles take aim at cancer. ACS Nano 2008, 2:2200-2205.
152. Pelaz B., Charron G., Pfeiffer C., Zhao Y., de la Fuente J.M., Liang X.-J., Parak W.J., del Pino P. Interfacing Engineered Nanoparticles with Biological Systems: Anticipating Adverse Nano-Bio Interactions. SMALL 2012, 10.1002/smll.201201229.
153. Karmali P.P., Simberg D. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin. Drug Deliv. 2011, 8:343-357.
154. Lipka M., Semmler-Behnke M., Sperling R.A., Wenk A., Takenaka S., Schleh C., Kissel T., Parak W.J., Kreyling W.G. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 2010, 31:6574-6581.